Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of a Novel 532-nm Picosecond Nd:YAG Laser for the Treatment of Freckles in Chinese Patients: A Prospective, Randomized, Split-Face Controlled Study

NCT07352631 is registered in ClinicalTrials.gov with Beijing Hospital as lead sponsor.

NCT NCT07352631
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07352631 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of a Novel 532-nm Picosecond Nd:YAG Laser for the Treatment of Freckles in Chinese Patients: A Prospective, Randomized, Split-Face Controlled Study
Lead sponsor
Beijing Hospital
Phase
Not applicable
Overall status
Completed
Start date
December 11, 2024
Completion date
August 27, 2025
Enrollment
84 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

freckles